Get the Stockscreener App
0.6442
0.76%
-0.0108
Bone Biologics Corp stock is traded at $0.6442, with a volume of 228.43K.
It is down -0.76% in the last 24 hours and down -44.44% over the past month.
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
See More
Previous Close:
$0.655
Open:
$0.645
24h Volume:
228.43K
Relative Volume:
0.75
Market Cap:
$1.17M
Revenue:
-
Net Income/Loss:
$-2.86M
P/E Ratio:
-0.257
EPS:
-2.5071
Net Cash Flow:
$-2.57M
1W Performance:
-26.10%
1M Performance:
-44.44%
6M Performance:
-41.96%
1Y Performance:
-70.45%
1-Day Range:
$0.6185
$0.6698
1-Week Range:
$0.6185
$0.975
52-Week Range:
$0.6185
$4.1299
Bone Biologics Corp Stock (BBLG) Company Profile
Name
Bone Biologics Corp
Sector
Industry
Phone
(781) 552-4452
Address
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
0.647 | 1.19M | 0 | -2.86M | -2.57M | -2.5071 |
VRTX
Vertex Pharmaceuticals Inc
|
515.76 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.65 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
990.87 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
211.83 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.63 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Bone Biologics Corp Stock (BBLG) Latest News
Bone Biologics Raises $2.7M, Extends Cash Runway to Q2 2027 - Minichart
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Bone Biologics Extends rhNELL-1 Validated Shelf Life to 32 Months as NB1 Study Advances - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Bone Biologics Corporation Achieves 32-Month Validated Shelf Life For rhNELL-1 - marketscreener.com
Bone Biologics Corp expected to post a loss of 39 cents a shareEarnings Preview - TradingView
Bone Biologics Corp (BBLG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
US: Halma sells NovaBone to Keensight-backed Isto Biologics for US$60m - Investors in Healthcare
Bone Biologics Warrants (BBLGW) Steady at $8.0 as Tight Trading Range Takes ShapeValue ETF - dars.gov.et
Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone - Orthopedics This Week
Isto Biologics Acquires NovaBone | Press Release - ACCESS Newswire
Bone Biologics Warrants (BBLGW) Hold Flat at $8.00 as Range-Bound Trading PersistsMA Cross Alert - dars.gov.et
Bone Biologics Corp Warrants (BBLGW) Hold Steady at $8.0 Amid Low Volume ConsolidationBullish Sentiment - dars.gov.et
Bone Biologics Corp (BBLG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bone Biologics Corp Warrants (BBLGW) Holds Steady at $8.0 as Consolidation Pattern EmergesMESA MA - po-news-eg.net
Bone Biologics Corp (BBLG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bone Biologics Corp SEC Filing (Jul 27, 2026) - Stock Titan
Bone Biologics Corp (BBLG) Cash Flow - TradingKey
Bone Biologics Corp (BBLG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bone Biologics Corp (BBLG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BBLG|Bone Biologics Corp|Price:1.070|Chg%:-0.010 - TradingKey
BBLG|Bone Biologics Corp|Price:1.010|Chg%:-0.060 - TradingKey
Bone Biologics Corp (BBLG) Nears Support as Selling Pressure PersistsRetail Driven Moves - dars.gov.et
Bone Biologics Corp Revenue Breakdown – NASDAQ:BBLGW - TradingView
TradingKey - TradingKey
Bone Biologics Corp Revenue Breakdown – NASDAQ:BBLG - TradingView
Bone Biologics Corp (BBLG) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bone Biologics raises $3.0M in July financing, extends rhNELL-1 shelf life to 29 months - TradingView
Bone Biologics (Nasdaq: BBLG) raises $3M, extends runway to 2027 - Stock Titan
Bone Biologics extends rhNELL-1 shelf life to 29 months - Stock Titan
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities - Yahoo Finance
Bone Biologics Holds Near Support After Modest DeclineButterfly Setup - dars.gov.et
Price to book forward of Bone Biologics Corp – NASDAQ:BBLG - TradingView
Price to sales forward of Bone Biologics Corp – NASDAQ:BBLG - TradingView
Bone Biologics Corp (BBLG) Q1 2026 Earnings: Narrower-than-expected loss fails to lift stockSegment Revenue Breakdown - dars.gov.et
Form S-3 Bone Biologics Corp For: 17 July - Investing.com India
Form S-3 Bone Biologics Corp For: 17 July By Investing.com - Investing.com Nigeria
Bone Biologics (NASDAQ: BBLG) registers 6.46M warrant shares for resale - Stock Titan
Bone Biologics Corporation Files Form 8-K with SEC: Company Details, Stock Info, and Contact Information (July 2026) - Minichart
Bone postpones 2026 annual meeting to Sept. 28, sets new record date Aug. 6 - TradingView
Bone Biologics (NASDAQ: BBLG) delays 2026 meeting to September 28 - Stock Titan
World Fiber Viable Bone MatrixMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Enterprise value to revenue forward of Bone Biologics Corp – NASDAQ:BBLG - TradingView
Enterprise value to EBITDA forward of Bone Biologics Corp – NASDAQ:BBLG - TradingView
Bone Biologics Corp (BBLG) Q1 2026 Earnings: Narrower Loss Surprises; Stock Holds SteadyEarnings Miss Streak - dars.gov.et
Price to sales forward of Bone Biologics Corp – BOATS:BBLGW - TradingView
Enterprise value to EBIT forward of Bone Biologics Corp – BOATS:BBLGW - TradingView
Enterprise value to revenue forward of Bone Biologics Corp – BOATS:BBLGW - TradingView
Orthobiologics Devices And Equipment Market Report 2026 Market Outlook Supported By A Forecast 8% CAGR - openPR.com
Bone Biologics Announces $9 Million Private Placement for Spine Fusion Innovation and Clinical Trials Funding 12 - Minichart
Bone Biologics Corp Stock (BBLG) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.24%
1.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):